Akebia Therapeutics Announces Pricing of Public Offering of Common Stock
The shares are being offered by Akebia pursuant to a shelf registration statement that was filed with the Securities and Exchange Commission (“SEC”) on September 3, 2024 and declared effective by the ...
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion ...
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ...